Yu et al. developed TMZ-loaded gold nanoparticles (TMZ@GNPs) modified with Anti-Erythropoietin-Producing Hepatocellular Carcinoma A3 (EphA3) to combat TMZ resistance in glioblastoma. Here, EPHA3 is linked to glioblastoma.